Trial Profile
Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2019
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Histamine H2 receptor antagonists; Proton pump inhibitors
- Indications Gastrointestinal disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 27 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 04 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Planned number of patients changed from 1500 to 11000 as reported by ClinicalTrials.gov record.